Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 180 | 236 | 1,645 | 269 | 404 |
Gross Profit | 180 | 236 | 1,645 | 269 | 404 |
Operating Expenses | 47,230 | 40,591 | 39,368 | 40,141 | 47,734 |
Operating Income | -47,050 | -40,355 | -37,723 | -39,872 | -47,330 |
Other Income | -1,042 | 979 | -1,807 | 882 | -1,112 |
Pre-tax Income | -48,092 | -39,376 | -39,530 | -38,990 | -48,442 |
Income Tax | -6,426 | -5,385 | -6,357 | -5,724 | -5,581 |
Net Income Continuous | -41,666 | -33,991 | -33,173 | -33,266 | -42,861 |
Net Income | $-41,666 | $-33,991 | $-33,173 | $-33,266 | $-42,861 |
EPS Basic Total Ops | -0.50 | -0.47 | -0.47 | -0.53 | -0.82 |
EPS Basic Continuous Ops | -0.50 | -0.47 | -0.47 | -0.53 | -0.82 |
EPS Diluted Total Ops | -0.50 | -0.47 | -0.47 | -0.53 | -0.82 |
EPS Diluted Continuous Ops | -0.50 | -0.47 | -0.47 | -0.53 | -0.82 |
EBITDA(a) | $-44,946 | $-37,907 | $-35,479 | $-38,210 | $-45,668 |